Exact Sciences posted $102.9 million in second quarter 2018 revenue, missing investor predictions by $1.8 million, or 1.7 percent, causing its stock to fall 18.75 percent.
Exact Sciences is sponsoring Fight Colorectal Cancer and PGA Tour professional Tom Lehman to promote Fight CRC.
RedHill Biopharma’s Crohn’s disease drug, RHB-104, successfully met its primary and secondary endpoints, achieving remission at 26 weeks.
More articles on gastroenterology:
Actor Matthew Perry undergoes tracheostomy in Los Angeles hospital — 5 insights
ASGE recognizes Metropolitan Gastroenterology Consultants — 3 insights
Dr. William Karnes: Key trends and challenges in GI today
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
